Literature DB >> 1409392

Calcium alginate beads as core carriers of 5-aminosalicylic acid.

S Y Lin1, J W Ayres.   

Abstract

The utilization of calcium alginate beads as core carriers for delayed dissolution followed by burst release as a potential method of intestinal site specific drug delivery was investigated. 5-Aminosalicylic acid was spray-coated on dried calcium alginate beads and then coated with different percentages of enteric coating polymer and/or sustained-release polymer. Beads coated with more than 6% (w/w) methacrylic copolymer plastisized with dibutyl sebacate and triethyl citrate resisted release in 2-hr acid fluid challenge and allowed immediate dissolution upon transfer to simulated intestinal fluid. With 6% (w/w) methacrylic copolymer on top of 4% (w/w) ethylcellulose polymer, the major portion of drug did not release in 2 hr of acid treatment or the next 3 hr of simulated intestinal fluid treatment. This dosage form provides the possibility to deliver drug to the lower intestinal tract with minimal early release, followed by sustained release in the colon.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1409392     DOI: 10.1023/a:1015887318767

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  12 in total

1.  New enema treatments for inflammatory bowel disease.

Authors:  L C Karp; S R Targan
Journal:  Dig Dis Sci       Date:  1988-03       Impact factor: 3.199

2.  Treatment of ulcerative colitis with high-dose 5-aminosalicylic acid enemas.

Authors:  M Campieri; G A Lanfranchi; G Bazzocchi; C Brignola; F Sarti; G Franzin; A Battocchia; G Labo; P R Dal Monte
Journal:  Lancet       Date:  1981-08-08       Impact factor: 79.321

Review 3.  Sulfasalazine and related new drugs.

Authors:  M A Peppercorn
Journal:  J Clin Pharmacol       Date:  1987-04       Impact factor: 3.126

4.  Drug delivery to the proximal colon.

Authors:  J G Hardy; C G Wilson; E Wood
Journal:  J Pharm Pharmacol       Date:  1985-12       Impact factor: 3.765

5.  5-aminosalicylic acid in a slow-release preparation: bioavailability, plasma level, and excretion in humans.

Authors:  S N Rasmussen; S Bondesen; E F Hvidberg; S H Hansen; V Binder; S Halskov; H Flachs
Journal:  Gastroenterology       Date:  1982-11       Impact factor: 22.682

6.  5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis.

Authors:  L R Sutherland; F Martin; S Greer; M Robinson; N Greenberger; F Saibil; T Martin; J Sparr; E Prokipchuk; L Borgen
Journal:  Gastroenterology       Date:  1987-06       Impact factor: 22.682

7.  Immobilisation and mechanical, support of individual protoplasts.

Authors:  P Scheurich; H Schnabl; U Zimmermann; J Klein
Journal:  Biochim Biophys Acta       Date:  1980-06-06

8.  An oral preparation to release drugs in the human colon.

Authors:  M J Dew; P J Hughes; M G Lee; B K Evans; J Rhodes
Journal:  Br J Clin Pharmacol       Date:  1982-09       Impact factor: 4.335

9.  Microencapsulated islets as bioartificial endocrine pancreas.

Authors:  F Lim; A M Sun
Journal:  Science       Date:  1980-11-21       Impact factor: 47.728

Review 10.  Newer 5-aminosalicylic acid based drugs in chronic inflammatory bowel disease.

Authors:  G Järnerot
Journal:  Drugs       Date:  1989-01       Impact factor: 9.546

View more
  3 in total

1.  Colon targeted drug delivery systems: a review on primary and novel approaches.

Authors:  Anil K Philip; Betty Philip
Journal:  Oman Med J       Date:  2010-04

2.  T-Shaped Microfluidic Junction Processing of Porous Alginate-Based Films and Their Characteristics.

Authors:  Betul Mutlu; Muhammad Farhan; Israfil Kucuk
Journal:  Polymers (Basel)       Date:  2019-08-23       Impact factor: 4.329

Review 3.  The Structural Characteristics of Seaweed Polysaccharides and Their Application in Gel Drug Delivery Systems.

Authors:  Haowei Zhong; Xiaoran Gao; Cui Cheng; Chun Liu; Qiaowen Wang; Xiao Han
Journal:  Mar Drugs       Date:  2020-12-21       Impact factor: 5.118

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.